Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Just trying to understand your logic at this point. Every time the company plans to provide an update at a conference or in a filing, they had better strike a monetary partnership or release great material news. If not, the shorts are right to take the stock down by 40-50%, regardless of where it is already priced. Sounds logical, right? Let's take this down to 3 dollars, which is slightly above the value of cash on hand plus assets, thereby assigning a grand value of $0.25-$0.50 to the entire platform. All positives and future potential is completely baked in, absolutely none of the uncertainty is. Awesome!

ADXS management has certainly made a series of communication mistakes recently (investor day PR and update, HER2 confusion) and some errors of omission (not yet securing a major licensing deal. But none of it was worth a 40% beat down from what was an already absurd $7.41 share price (right before the current short attack). And to think that the company must go even lower, simply for not providing any additional material information right after this beat down is short logic at its finest.